FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073108512> ?p ?o ?g. }

• W2073108512 endingPage "216" @default.
• W2073108512 startingPage "210" @default.
• W2073108512 abstract "Recent evidence demonstrates that high doses of epoetin-alpha (EPO-α) can be administrated at extended intervals, despite its relatively short serum half-life. However, no prospective randomized trials on the effects of extended dosing intervals of EPO-α compared with darbepoetin-alpha (DA-α) have been performed. This study was designed to investigate whether a single biweekly (Q2W) administration of a high dose of EPO-α is as effective as DA-α for anemia in chronic kidney disease (CKD) patients not receiving dialysis. Sixty non-dialysis CKD patients were equally randomized to either Q2W subcutaneous EPO-α (10,000 unit) or DA-α (50 μg) therapy groups for the first 6 weeks. After a 6-week washout period, the participants of the EPO-α and DA-α treatment groups switched to the alternate regimen for 6 weeks. The mean hemoglobin (Hb) levels after erythropoiesis stimulating agent (ESA) therapy and percentage change in Hb levels from baseline to the end of the study were analyzed. The mean Hb levels of postESA therapy increased significantly compared with those of preESA therapy in both ESA regimens. The percentage increase in Hb levels and erythropoietin resistance index did not show a significant difference between the different ESA regimens. No difference was observed between the regimens regarding mean Hb levels after ESA therapy. Additionally, there were no serious adverse effects leading to withdrawal from treatment. Biweekly high doses of EPO-α therapy may be equally as effective as Q2W DA-α therapy in maintaining target Hb levels in non-dialysis CKD patients." @default.
• W2073108512 created "2016-06-24" @default.
• W2073108512 creator A5005415983 @default.
• W2073108512 creator A5007580413 @default.
• W2073108512 creator A5008026384 @default.
• W2073108512 creator A5009092529 @default.
• W2073108512 creator A5009985901 @default.
• W2073108512 creator A5058413853 @default.
• W2073108512 creator A5061986607 @default.
• W2073108512 creator A5073233577 @default.
• W2073108512 creator A5077382159 @default.
• W2073108512 date "2014-12-01" @default.
• W2073108512 modified "2023-09-23" @default.
• W2073108512 title "A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis" @default.
• W2073108512 cites W1967473081 @default.
• W2073108512 cites W1970157737 @default.
• W2073108512 cites W1984219766 @default.
• W2073108512 cites W1989661749 @default.
• W2073108512 cites W1998943227 @default.
• W2073108512 cites W2005973637 @default.
• W2073108512 cites W2021135607 @default.
• W2073108512 cites W2021159014 @default.
• W2073108512 cites W2033803279 @default.
• W2073108512 cites W2040029744 @default.
• W2073108512 cites W2049412796 @default.
• W2073108512 cites W2055142209 @default.
• W2073108512 cites W2066043985 @default.
• W2073108512 cites W2089264894 @default.
• W2073108512 cites W2094875169 @default.
• W2073108512 cites W2097391350 @default.
• W2073108512 cites W2105642896 @default.
• W2073108512 cites W2114572286 @default.
• W2073108512 cites W2118564242 @default.
• W2073108512 cites W2120612796 @default.
• W2073108512 cites W2134487085 @default.
• W2073108512 cites W2138393925 @default.
• W2073108512 cites W2139468731 @default.
• W2073108512 cites W2139537558 @default.
• W2073108512 cites W2142926804 @default.
• W2073108512 cites W2148520689 @default.
• W2073108512 cites W2415221803 @default.
• W2073108512 cites W2580449060 @default.
• W2073108512 cites W2584947097 @default.
• W2073108512 cites W2129134611 @default.
• W2073108512 cites W2412505776 @default.
• W2073108512 doi "https://doi.org/10.1016/j.krcp.2014.10.001" @default.
• W2073108512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4714283" @default.
• W2073108512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26885479" @default.
• W2073108512 hasPublicationYear "2014" @default.
• W2073108512 type Work @default.
• W2073108512 sameAs 2073108512 @default.
• W2073108512 citedByCount "2" @default.
• W2073108512 countsByYear W20731085122017 @default.
• W2073108512 countsByYear W20731085122023 @default.
• W2073108512 crossrefType "journal-article" @default.
• W2073108512 hasAuthorship W2073108512A5005415983 @default.
• W2073108512 hasAuthorship W2073108512A5007580413 @default.
• W2073108512 hasAuthorship W2073108512A5008026384 @default.
• W2073108512 hasAuthorship W2073108512A5009092529 @default.
• W2073108512 hasAuthorship W2073108512A5009985901 @default.
• W2073108512 hasAuthorship W2073108512A5058413853 @default.
• W2073108512 hasAuthorship W2073108512A5061986607 @default.
• W2073108512 hasAuthorship W2073108512A5073233577 @default.
• W2073108512 hasAuthorship W2073108512A5077382159 @default.
• W2073108512 hasBestOaLocation W20731085121 @default.
• W2073108512 hasConcept C126322002 @default.
• W2073108512 hasConcept C142724271 @default.
• W2073108512 hasConcept C168563851 @default.
• W2073108512 hasConcept C197934379 @default.
• W2073108512 hasConcept C204787440 @default.
• W2073108512 hasConcept C27081682 @default.
• W2073108512 hasConcept C2776164570 @default.
• W2073108512 hasConcept C2777288759 @default.
• W2073108512 hasConcept C2778063415 @default.
• W2073108512 hasConcept C2778248108 @default.
• W2073108512 hasConcept C2778534260 @default.
• W2073108512 hasConcept C2778653478 @default.
• W2073108512 hasConcept C2779978075 @default.
• W2073108512 hasConcept C2781404941 @default.
• W2073108512 hasConcept C2781413609 @default.
• W2073108512 hasConcept C71924100 @default.
• W2073108512 hasConcept C87813604 @default.
• W2073108512 hasConceptScore W2073108512C126322002 @default.
• W2073108512 hasConceptScore W2073108512C142724271 @default.
• W2073108512 hasConceptScore W2073108512C168563851 @default.
• W2073108512 hasConceptScore W2073108512C197934379 @default.
• W2073108512 hasConceptScore W2073108512C204787440 @default.
• W2073108512 hasConceptScore W2073108512C27081682 @default.
• W2073108512 hasConceptScore W2073108512C2776164570 @default.
• W2073108512 hasConceptScore W2073108512C2777288759 @default.
• W2073108512 hasConceptScore W2073108512C2778063415 @default.
• W2073108512 hasConceptScore W2073108512C2778248108 @default.
• W2073108512 hasConceptScore W2073108512C2778534260 @default.
• W2073108512 hasConceptScore W2073108512C2778653478 @default.
• W2073108512 hasConceptScore W2073108512C2779978075 @default.
• W2073108512 hasConceptScore W2073108512C2781404941 @default.
• W2073108512 hasConceptScore W2073108512C2781413609 @default.
• W2073108512 hasConceptScore W2073108512C71924100 @default.

• next